Latest News
| Cerveau Technologies, Inc. to Support a First Clinical Study in Asia of a Novel Biomarker of Alzheimer’s Disease | |
 |
13 December 2018 BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced that the Memory Aging and Cognition Centre (MACC) at the National University Health System (NUHS) in Singapore has initiated a study with an early stage imaging agent [18F]MK-6240 to be used in Positron Emission Tomography (PET) scans for assessing the level and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a hallmark of several neurodegenerative diseases, including Alzheimer’s disease. Read more |
| A*STAR-NUS Centre for research imaging in diseases opens |
|
 |
11 November 2015 The centre will be the first in Southeast Asia to use Latest technologies like MR/PET scanner, known as the magnetic resonance (MR) imaging-compatible positron emission tomographic (PET). |
| Clinical Imaging's answer to the Hubble Telescope |
|
 |
23 October 2015 The powerful imaging technologies at the A*STAR-NUS Clinical Imaging Research Centre are helping clinicians and medical scientists see and understand the human body and disease progression in a whole new way. Read more |
| Award presented to Professor David Townsend in recognition for his achievements in PET physics | |
 |
7 June 2015 David Townsend, professor in the Department of Diagnostic Imaging at the National University of Singapore and director of the A*STAR-NUS Clinical Imaging Research Centre in Singapore, has been named this year’s recipient of the prestigious Paul C. Aebersold Award. |
